Home > Insider Trading > Filing (0001104659-22-110047)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1633070	Axcella Health Inc.	AXLA	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1774662	William Hinshaw	C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-10-17	50,000	$0.00	98,012	No	4	A	Direct
Common Stock	Disposition	2022-10-19	16,000	$1.56	82,012	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

On September 29, 2020, the Reporting Person was granted 50,000 restricted stock units ("RSUs"), which vest upon satisfaction of certain performance criteria. On October 17, 2022, the Issuer's Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such RSUs.
Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.52 to $1.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.